Xxera/openscience/retractions

Record #68207

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer

Daniel Chan, Yun Zheng, Jeffrey W Tyner, Wee Joo Chng, Wen Wen Chien, Sigal Gery, Geraldine Leong, Glenn D Braunstein, H Phillip Koeffler

Journal

Journal of Cancer Research and Clinical Oncology

Publisher

Springer - Nature Publishing Group

Original paper date

Jul 4, 2013

Original DOI

10.1007/s00432-013-1465-6

Country

🇨🇳 China · 🇸🇬 Singapore · 🇺🇸 United States

Institution

National University Hospital, National University Cancer Institute Singapore, 1E Kent Ridge Road, Singapore, 119228, Singapore · Division of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA · Oregon Health and Science University, 3181 S.W. Sam Jackson Park Rd., Portland, OR, 97239-3098, USA · Cancer Science Institute Singapore, Centre for Translational Medicine, NUS, 14 Medical Drive, MD6, #12-01, Singapore, 117599, Singapore · State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, 651 Dongfeng East Rd, Guangzhou, 510060, People’s Republic of China

Open access

No

Article type

Research Article

Broad categories

(HSC) Medicine - Endocrinology (HSC) Medicine - Oncology (HSC) Medicine - Pharmacology

Notes from Retraction Watch

See also: https://pubpeer.com/publications/5F78261DA479AEB4D7B47C004B3404

Citation lifecycle

How this paper is being cited

Pre-retraction

40

Same day

0

Post-retraction

0

% post-retraction

0.0%

~3.3 citations/yr before retraction · ~0.0 citations/yr after

— citing papers

Who is still citing this work

Loading…